My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

0.5546 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 Next >

Earnings Scheduled For March 12, 2025 ↗

March 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 07, 2024

Via Benzinga

A Preview Of Harvard Bioscience's Earnings ↗

March 06, 2024

Via Benzinga

Earnings Preview For Harvard Bioscience ↗

November 06, 2023

Via Benzinga

Preview: Harvard Bioscience's Earnings ↗

August 07, 2023

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Examining the Future: Harvard Bioscience's Earnings Outlook ↗

May 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 06, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Tuesday's session. ↗

April 08, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

HBIO Stock Earnings: Harvard Bioscience Misses Revenue for Q2 2024 ↗

August 08, 2024

HBIO stock results show that Harvard Bioscience missed on revenue for the second quarter of 2024.

Via InvestorPlace

Why Harvard Bioscience Stock Rose This Week ↗

April 27, 2023

The company reported improved revenue in Q1.

Via The Motley Fool

Harvard Bioscience's Return On Capital Employed Overview ↗

March 14, 2023

Via Benzinga

Earnings Preview: Harvard Bioscience ↗

March 08, 2023

Via Benzinga

Holley And 2 Other Stocks Under $5 Insiders Are Buying ↗

June 17, 2024

Via Benzinga

FlexShopper And 3 Other Stocks Under $5 Insiders Are Buying ↗

June 10, 2024

Via Benzinga

HBIO Stock Earnings: Harvard Bioscience Meets EPS, Misses Revenue for Q1 2024 ↗

May 07, 2024

HBIO stock results show that Harvard Bioscience met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

HBIO Stock Earnings: Harvard Bioscience Misses EPS, Misses Revenue for Q4 2023 ↗

March 07, 2024

HBIO stock results show that Harvard Bioscience missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 30, 2023

Via Benzinga

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff This Quarter ↗

April 17, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Over $7M Bet On This Consumer Defensive Stock? Check Out These 4 Penny Stocks Insiders Are Buying ↗

March 16, 2023

The Dow Jones closed lower by more than 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

10 Stocks Under $10 for 2023 ↗

January 03, 2023

In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10.

Via InvestorPlace

Earnings Preview: Harvard Bioscience ↗

November 07, 2022

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Harvard...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 22, 2022

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Via Benzinga

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying ↗

August 19, 2022

U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 12, 2022

On Friday, 39 companies reached new 52-week lows.

Via Benzinga

Looking Into Harvard Bioscience's Return On Capital Employed ↗

May 19, 2022

Harvard Bioscience (NASDAQ:HBIO) brought in sales totaling $28.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 815.92%, resulting in a loss of $6.88...

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 05, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 04, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...

Via Benzinga

Recap: Harvard Bioscience Q1 Earnings ↗

May 04, 2022

Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.